TEM-187, a new extended-spectrum β-lactamase with weak activity in a Proteus mirabilis clinical strain.

Corvec, Stéphane

TEM-187, a new extended-spectrum β-lactamase with weak activity in a Proteus mirabilis clinical strain. [electronic resource] - Antimicrobial agents and chemotherapy May 2013 - 2410-2 p. digital

Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't

1098-6596

10.1128/AAC.01761-12 doi


Amino Acid Substitution
Anti-Bacterial Agents--pharmacology
Base Sequence
Drug Resistance, Multiple, Bacterial--genetics
Humans
Microbial Sensitivity Tests
Molecular Sequence Data
Proteus Infections--drug therapy
Proteus mirabilis--drug effects
beta-Lactamases--genetics